Best Practices for Implementing Dual Endothelin Angiotensin Receptor Antagonist Therapeutics in Patients with IgAN - Module I

Jun 18, 2024

- Jun 17, 2025

Best Practices for Implementing Dual Endothelin Angiotensin Receptor Antagonist Therapeutics in Patients with IgAN

0.5

Claim your AMA PRA Category 1 Credit(s), CNE Contact Hour(s) or CPE Contact Hour(s) (CEUs)

This course is available for logged in users only. Please login or register to take the course.

Management of Patients with Non-Cystic Fibrosis Bronchiectasis: Reducing Burden of Disease...

The Role of Complement Pathway Inhibitors in the Management of Chronic Inflammatory Demyel...

Will We See a New Paradigm for SPAF? Which Patients Are More Likely to Benefit from FXIa I...